AH Equity Partners Bio II, L.L.C. - Q4 2021 holdings

$192 Million is the total value of AH Equity Partners Bio II, L.L.C.'s 4 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q4 2021
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
EQRx, Inc.4Q3 202261.9%
Nautilus Biotechnology, Inc.4Q3 202240.8%
Erasca, Inc.4Q3 202220.3%
InVitae Corporation4Q3 20229.3%

View AH Equity Partners Bio II, L.L.C.'s complete holdings history.

Latest filings
TypeFiled
42023-11-09
42023-01-04
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
32021-12-22
32021-06-09

View AH Equity Partners Bio II, L.L.C.'s complete filings history.

Export AH Equity Partners Bio II, L.L.C.'s holdings